TZ30

TZ – Research Use Only (RUO)
Tirzepetide (Research Peptide)
TZ is a synthetic dual GIP/GLP-1 receptor pathway agonist frequently referenced in metabolic signaling studies, multi-receptor interaction models, and biochemical investigations involving incretin-related pathways. Because of its unique dual-target design and high structural stability, TZ is widely utilized in controlled in-vitro laboratory environments for pathway modeling and assay development.
Researchers value TZ due to its:
Dual-receptor activity profile, useful for studying complex metabolic signaling interactions
Stable peptide structure, supporting multi-phase experimental designs
Relevance to incretin-based biochemical research
Compatibility with metabolic, molecular, and receptor-binding assay models
High reproducibility, allowing consistent laboratory outcomes
TZ is intended exclusively for laboratory investigation, in-vitro experimentation, and biochemical pathway exploration.
Research Applications (RUO Only)
TZ has been referenced in controlled scientific environments examining:
GIP and GLP-1 receptor signaling models
Dual-agonist peptide interaction pathways
Metabolic and enzymatic regulatory mechanisms
Comparative incretin pathway studies
Molecular assays involving multi-receptor modulation
(No human or veterinary use implied or permitted.)
Compliance Notice
This material is supplied strictly for Research Use Only.
Not for human or veterinary consumption, administration, injection, or therapeutic use.
Not evaluated by the FDA.